Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $13.0 in the prior trading day, RxSight Inc (NASDAQ: RXST) closed at $13.12, up 0.92%. In other words, the price has increased by $0.92 from its previous closing price. On the day, 0.82 million shares were traded. RXST stock price reached its highest trading level at $13.34 during the session, while it also had its lowest trading level at $12.77.
Ratios:
Our goal is to gain a better understanding of RXST by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.65 and its Current Ratio is at 12.68. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
On April 15, 2025, Piper Sandler started tracking the stock assigning a Neutral rating and target price of $18.
UBS Downgraded its Buy to Neutral on April 09, 2025, while the target price for the stock was maintained at $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 12 ’25 when Fountain Tamara sold 7,000 shares for $25.71 per share. The transaction valued at 180,002 led to the insider holds 24,793 shares of the business.
TAMARA R FOUNTAIN bought 7,000 shares of RXST for $180,002 on Mar 12 ’25. On Jan 22 ’25, another insider, Maniar Shweta, who serves as the Director of the company, sold 3,519 shares for $30.87 each. As a result, the insider received 108,618 and left with 7,383 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXST now has a Market Capitalization of 533157440 and an Enterprise Value of 310981760. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.59 while its Price-to-Book (P/B) ratio in mrq is 1.91. Its current Enterprise Value per Revenue stands at 2.097 whereas that against EBITDA is -9.248.
Stock Price History:
The Beta on a monthly basis for RXST is 1.21, which has changed by -0.76978415 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, RXST has reached a high of $59.67, while it has fallen to a 52-week low of $12.53. The 50-Day Moving Average of the stock is -9.90%, while the 200-Day Moving Average is calculated to be -58.30%.
Shares Statistics:
The stock has traded on average 1.05M shares per day over the past 3-months and 679110 shares per day over the last 10 days, according to various share statistics. A total of 40.59M shares are outstanding, with a floating share count of 37.76M. Insiders hold about 7.08% of the company’s shares, while institutions hold 92.03% stake in the company. Shares short for RXST as of 1749772800 were 4962460 with a Short Ratio of 4.73, compared to 1747267200 on 4922725. Therefore, it implies a Short% of Shares Outstanding of 4962460 and a Short% of Float of 12.82.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
